Gujarat, India

Harish Shandilya

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Intas Pharmaceuticals Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harish Shandilya. Retrieved from https://idiyas.com/inventor/harish-shandilya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harish Shandilya: Innovator in Biotechnology

Introduction

Harish Shandilya is a prominent inventor based in Gujarat, India. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing biologically active proteins.

Latest Patents

Harish Shandilya holds a patent for a "Cloning, expression and purification method for the preparation of ranibizumab." This innovative method involves a polynucleotide sequence and a technique for cloning, expression, and production of Ranibizumab, which results in better yield and biologically active protein. He has 1 patent to his name.

Career Highlights

Harish is currently employed at Intas Pharmaceuticals Limited, where he applies his expertise in biotechnology to advance pharmaceutical development. His work has been instrumental in enhancing the efficiency of protein production processes.

Collaborations

Some of his notable coworkers include Himanshu Gadgil and Vivek Farkade, who have collaborated with him on various projects within the company.

Conclusion

Harish Shandilya's contributions to biotechnology, particularly through his innovative patent, highlight his role as a key figure in the field. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…